VANDRIA
Vandria creates mitophagy inducers that renew cells in order to address aging and chronic disorders.
VANDRIA
Social Links:
Industry:
Manufacturing Pharmaceutical
Founded:
2021-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.vandria.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
21.5 M CHF
Technology used in webpage:
Amazon Smart App Banner Nextcloud
Investors List
Eurostars
Eurostars investment in Grant - Vandria
Innosuisse
Innosuisse investment in Grant - Vandria
+ND Capital
+ND Capital investment in Series A - Vandria
Official Site Inspections
http://www.vandria.com Semrush global rank: 7 M Semrush visits lastest month: 945
- Host name: ec2-54-194-41-141.eu-west-1.compute.amazonaws.com
- IP address: 54.194.41.141
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Vandria"
Vandria - Crunchbase Company Profile & Funding
The investment led by ND Capital indicates confidence in Vandria's potential within the pharmaceutical industry, particularly in the area of cell renewal to …See details»
Vandria.com — Page 6
Klaus, CEO and board member of Vandria, brings over 18 years of leadership in top 50 pharma companies, including 8.5 years as CMO at Boehringer Ingelheim and Ferring. He has …See details»
Vandria.com — News - Press release n°3
Aug 21, 2024 Vandria’s pipeline offers even wider potential to address other age-related and chronic diseases of the muscle, lung and liver. ... Hevolution Foundation is a first-of-its-kind …See details»
Vandria Company Profile 2024: Valuation, Funding
Vandria General Information Description. Developer of mitophagy inducers designed to rejuvenate cells to treat age-related and chronic diseases. The …See details»
Vandria - BioAlps
Vandria’s purpose is to research, develop, manufacture and market pharmaceutical products in the life sciences field, in particular the development of products to combat diseases linked to …See details»
Vandria Company Profile - Office Locations, Competitors ... - Craft
Vandria has 5 employees at their 1 location and $20.6 m in total funding,. See insights on Vandria including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Vandria - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... obfuscated +ND Capital, Hevolution: …See details»
Vandria.com — Team
Our team is made of world class scientists and medical professionals. Our board features leading members of the Life Science and Pharmaceutical industries.See details»
Vandria - VentureRadar
Vandria has built a proprietary in vitro screening platform and generated a novel pipeline of next generation small molecule mitophagy inducers. Vandria’s compounds are tailored for their …See details»
Hevolution Foundation and Dolby Family Ventures join Vandria’s …
Aug 21, 2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer …See details»
Vandria - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Vandria SA is a …See details»
Series A - Vandria - 2024-08-21 - Crunchbase Funding Round Profile
Aug 21, 2024 GlobeNewswire News Room — Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M). …See details»
Vandria.com — Science
Vandria develops best-in-class mitophagy inducers that rejuvenate cells by restoring mitochondrial health. Mitochondrial health determines the level of functionality of our cells and …See details»
Vandria raises USD 20.6M and emerges from stealth
Dec 15, 2023 Vandria was spun out of Amazentis SA in 2021 with backing from ND Capital to develop first-in-class small molecule mitophagy inducers against a novel target to rejuvenate …See details»
Hevolution Foundation and Dolby Family Ventures join Vandria’s …
Aug 21, 2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer …See details»
Vandria Announces a CHF 18 Million Fundraising - BioAlps
Nov 1, 2024 Vandria was spun out of Amazentis SA in 2021 with backing by ND Capital to develop first-in-class small molecule mitophagy inducers against a novel target to rejuvenate …See details»
Vandria.com — News
Dec 14, 2023 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer …See details»
Vandria Gains Momentum with $20.6M Funding to Propel
Dec 18, 2023 Vandria SA, a Swiss biotechnology firm specializing in mitochondrial therapeutics, recently announced a significant milestone in its journey. The company has secured $20.6 …See details»
Vandria.com — Pipeline
Vandria has built a proprietary in vitro screening platform and generated a novel pipeline of next generation small molecule mitophagy inducers. Vandria’s compounds are tailored for their …See details»